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 Fetal Alcohol Spectrum Disorders (FASDs) are comprised of developmental, 
behavioral, and cognitive abnormalities caused by prenatal alcohol exposure, affecting an 
estimated 2%-5% of children and costing up to $4 billion annually in the United States 
alone. Although some behavioral therapies can help, the biochemical mechanisms that 
underpin FASDs need further elucidation for development of more efficacious 
therapeutics. The tau protein modulates cytoskeletal structure in neurons, and thereby plays 
an integral role in proper development and function of the central nervous system, but its 
function is altered by its phosphorylation state, such that increased phosphorylation reduces 
tau protein function. The tau protein is highly phosphorylated at birth but becomes 
dephosphorylated during structural maturation. Aberrant tau hyperphosphorylation is 
cardinal of neurodegenerative diseases, but less is known about its role in 
neurodevelopmental disorders, like FASD. In the neonatal rat model of organotypic 
hippocampal slice culture, tau phosphorylation decremented in all measured regions of the 
control hippocampus across 24 days in vitro, but tau hyperphosphorylation was sustained 
in all regions except the CA3 in hippocampal slices that were exposed to alcohol. Future 
research should investigate the functional, behavioral, and cognitive relevance of 
hyperphosphorylated tau protein with regard to FASDs to identify potential therapeutics. 
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CHAPTER 1. INTRODUCTION 
1.1 Fetal Alcohol Spectrum Disorders 
Fetal Alcohol Spectrum Disorders (FASD) is a non-diagnostic umbrella term 
which includes patients who are diagnosed with partial or full Fetal Alcohol Syndrome 
(pFAS; FAS), alcohol-related neurodevelopmental disorder (ARND), alcohol-related 
birth defects (ARBD), and neurobehavioral disorder associated with prenatal alcohol 
exposure (ND-PAE). These conditions are diagnostically spectral, with FAS patients 
presenting a greater magnitude of physical (lower birth weight, thin vermilion, smooth 
philtrum, flat midface, shortened palpebral fissure) and neurodevelopmental 
(microcephaly, cerebellar hypoplasia) abnormalities compared to other FASDs (Bertrand 
et al., 2004; Ferreira & Cruz, 2017; Jones & Smith, 1973; Kully-Martens, Denys, Treit, 
Tamana, & Rasmussen, 2019). Though FASDs are the most preventable causes of mental 
retardation, an estimated 2-5% of children are affected by FASDs and disburse up to $4 
billion in annual costs in the United States alone (Lupton, Burd, & Harwood, 2004; May 
et al., 2009). Recently, up to 11.5% of women reported drinking during the time of 
pregnancy, and 3.9% reported binge drinking within the last 30 days of the pregnancy 
(Denny, Acero, Naimi, & Kim, 2019). In some domains, binge alcohol consumption 
during pregnancy induces more severe deficits compared to moderate, chronic alcohol 
consumption (Bonthius, Goodlett, & West, 1988; Sood et al., 2001) though no amount of 
alcohol consumption is safe at any stage of pregnancy (Williams & Smith, 2015).  
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Alcohol exposure at different fetal stages has varying effects on the developing 
central nervous system (CNS); earlier fetal alcohol exposure during the embryonic periods 
results in the cardinal craniofacial abnormalities in the human along with forebrain and 
brain stem developmental perturbations in macaques and Sprague-Dawley rats, 
respectively (Ernhart et al., 1987; Miller, 2007; Mooney & Miller, 2007; Sulik, 2005). Data 
from both rodent and human studies show that alcohol exposure prior to and briefly after 
birth has a greater magnitude of influence on neural and glial migration and viability, 
resulting in hippocampal, cortical, and corpus colossal defects leading to diminished 
overall brain volume and white matter insulation compared to unexposed groups (Gressens, 
Lammens, Picard, & Evrard, 1992; Miller, 1995; Riley et al., 2005; Rubert, Miñana, 
Pascual, & Guerri, 2006; Sowell et al., 2001). These deficits result in several behavioral 
and cognitive abnormalities in humans which practitioners primarily rely on for diagnosis 
(Mattson, Crocker, & Nguyen, 2011). Notable deficits observed in FASDs include, but are 
not limited to, diminished intellectual capacity, attention, executive and adaptive 
functioning, and learning and memory. 
1.1.1 Intelligence 
In general, individuals with FASDs have a restricted intellectual capacity with a 
broad IQ range between 20-120 (Mattson & Riley 1998; Streissguth, Barr, Kogan, & 
Bookstein, 1996); however, even those most severely affected by FASDs usually have 
IQs greater than 70 (i.e. do not meet criteria for intellectual disability; Mattson et al., 
2011). Chasnoff et al. (2010) showed that there are some intellectual distinctions between 
FAS, pFAS, and ARND with regard to IQ and language-based memory where, 
predictably, individuals with FAS scored significantly worse than those with pFAS and 
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ARND; notably, there were no significant differences in any neurocognitive assessment 
between individuals with pFAS and ARND. Intelligence research on individuals with 
lower exposure to prenatal alcohol (pFAS and ARND) is lacking and many outcomes are 
inconclusive in part due to poor reporting of the timing and amount of alcohol exposure 
(Henderson, Gray, & Brocklehurst, 2007). Importantly, children with FASDs consistently 
perform worse in academic domains compared to non-FASDs children even after 
controlling for IQ, suggesting that general intelligence may only be one component of a 
milieu of neurocognitive factors that predict suboptimal academic performance (Glass et 
al., 2017; Goldschmidt et al., 1996).  
1.1.2 Attention 
Individuals with FASDs also show attention deficits and hyperactivity (Lee, 
Mattson, & Riley, 2007). Some of the most common attentional deficits seen in FASDs 
include efficiency of information processing, working memory, impulsivity, and reaction 
time – symptoms which overlap with attention deficit hyperactive disorder (ADHD; 
Jacobson, Jacobson, & Sokol, 1994; Kodituwakku, 2009; Rasmussen, 2005; Streissguth, 
2007). In fact, the cognitive and behavioral abnormalities between FASDs and ADHD 
are strikingly similar, though individuals with FASDs generally have lower IQs 
compared to individuals with ADHD (Bhatara, Loudenberg, & Ellis, 2006; Vaurio, Riley, 
Mattson, 2008; for a review, see Mattson, Bernes, & Doyle, 2019). FASDs remain the 
highest risk factor for developing ADHD in children, with prevalence of ADHD in 
individuals with FASDs reaching up to 94% (Bhatara et al., 2006; Fryer, McGee, Matt, 
Riley, & Mattson, 2007). This prevalence reflects the similar behavioral and cognitive 
presentations between FASDs and ADHD, but it should be noted that the diagnostic 
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distinctions may be muddied. An estimated >90% cases of FASDs are mis- or 
undiagnosed (Chasnoff, Wells, & King, 2015), which is likely due to the stigmatization 
and underreporting of maternal alcohol use (Corrigan et al., 2017; Morleo, 2011).   
1.1.3 Executive Functioning 
Children with FASDs present with poor executive functioning. Executive 
functioning encompasses some components of attention and appropriate physical activity 
levels, but additionally incorporates competency in problem solving, concept formation, 
set-shifting, and planning to achieve goal-directed behaviors (Anderson, 2002; Welsh & 
Pennington, 1988). Children with FASDs show significant deficits in the ability to 
generate and appropriately categorize abstract ideas when prompted; additionally, it has 
been shown that executive functioning may be impaired in individuals with FASDs due 
to the compounding difficulties with working memory and selective attention (Aragón, 
2008; McGee, Schonfeld, Roebuck-Spencer, Riley, & Mattson, 2008; Rasmussen, 2005). 
Subsequently, these executive functioning deficits impede on or entirely disrupt 
conceptualization, reasoning, and planning skills (Kodituwakku, Handmaker, Cutler, 
Weathersby, & Handmaker, 1995; McGee et al., 2008), which ultimately influence daily 
life and impair adaptive functioning. Taken together, this creates a familial, economic, 
and societal burden for those affected by FASDs (Greenmyer, Klug, Kambeitz, Popova, 
& Burd, 2018).  
1.1.4 Adaptive Functioning 
Diagnostic features of adaptive functioning operate within the three realms of 
communication, socialization, and daily living skills and are commonly evaluated using 
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the Vineland-3 assessment for individuals with intellectual disabilities (Sparrow, 
Cicchetti, & Saulnier, 2016). Cumulatively, these components promote personal and 
social independence – traits which are substandard in adult individuals with FASDs; 
these deficits are particularly exacerbated in conjunction with sensory processing deficits 
which is a common feature in those with FASDs (Åse et al., 2012; Jirikowic, Olson, & 
Kartin, 2008; Carr, Agnihotri, & Keightley, 2010). The affective impact of poor adaptive 
functioning in social outcomes in the FASDs population poses a significant risk of 
developing psychological disorders (Famy, Streissguth, & Unis, 1998; Fryer et al., 2007; 
O'Connor & Paley, 2009; for a review, see Weyrauch, Schwartz, Hart, Klug, & Burd, 
2017). Further, individuals prenatally exposed to alcohol are more likely to present with 
conduct disorders, substance use disorders, and legal trouble (Alati et al., 2008; Larkby, 
Goldschmidt, Hanusa, & Day, 2011; Streissguth et al., 2004). 
1.1.5 Learning and Memory 
Children with FASDs have impaired learning and memory skills regardless of IQ 
(Lewis et al., 2015; Mattson et al., 2011). Several of the deficits mentioned herein 
contribute to poor learning and memory outcomes in humans with FASDs, including 
attention, information processing, cognitive set shifting, working memory, and executive 
functioning (Aragón, 2008; Lee et al., 2007; Rasmussen, 2005). Poor memory 
consolidation, slower information processing and inefficient working memory are likely 
manifestations of the deleterious effects of alcohol on the developing hippocampus; in 
fact, magnetic resonance imaging (MRI) has revealed that truncated hippocampal 
development in FASDs is associated with impaired recall as evidenced by reduced 
hippocampal volume compared to age-matched controls (Willoughby, Sheard, Nash, & 
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Rovet, 2008). In pre- and neonatal alcohol-exposure rodent models of FASDs, alcohol 
exposure induces visuospatial learning and recall deficits, which is shown by a marked 
impairment to reach the escape platform in the Morris Water Maze Task compared to 
rodents who were not exposed to alcohol (Berman & Hannigan, 2000; Goodlett & 
Johnson, 1997; Johnson & Goodlett, 2002). Wagner, Zhou, and Goodlett (2014) showed 
that learning deficits resulting from rodent neonatal binge alcohol exposure (human 3rd 
trimester equivalent) can persist into adolescence and adulthood. Due to its plastic role in 
learning and memory and susceptibility to alcohol insult, the hippocampus is an attractive 
candidate for investigation and potential mitigation of the developmental deficits 
observed in FASDs.  
1.2 Convergent Mechanisms of Pathology in the Hippocampus 
The functional role of the hippocampus is primarily involved in the synthesis and 
retrieval of episodic and contextual memories (Moscovitch, Nadel, Winocur, Gilboa, & 
Rosenbaum, 2005). Although the role of the hippocampus in long-term memory retrieval 
is debated, there is evidence to suggest that the hippocampus is necessary for long-term 
contextual and autobiographical retrieval in rodents and humans, respectively (Rekkas & 
Constable, 2005; Steinvorth, Levine, & Corkin, 2005; Sutherland, O'Brien, & Lehmann, 
2008). The synthesis of new memories is perhaps the most important role of the 
hippocampus and is certainly the most debilitating deficit in diseased and damaged states 
of the hippocampus. Memory-related pathologies such as age-related dementia and 
Alzheimer’s Disease (AD) target the hippocampus and the entorhinal cortex, though there 
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are distinct pathologies for each with respect to subregional hippocampal damage within 
the perforant pathway (Small, Schobel, Buxton, Witter, & Barnes, 2011). 
1.2.1 Neural Cytography  
The trisynaptic perforant pathway is comprised of the entorhinal cortex, dentate 
gyrus (DG), Cornu Ammonis 3 (CA3) subregion, Cornu Ammonis 2 (CA2) subregion, 
Cornu Ammonis (CA1) subregion, and the subiculum (Cembrowski & Spruston, 2019). 
The most explored regions of the hippocampus are the DG, CA3, and CA1 while greater 
contention exists over and less is known about the CA2 subregion (Small et al., 2011). 
Cell types that pervade the trisynaptic perforant pathway include granule cell layers of 
the DG which project mossy fiber axons toward interneurons and pyramidal neurons in 
the CA3; pyramidal neurons project Shaffer collateral axons throughout the pyramidal 
neurons of the CA3 and CA2 toward pyramidal neurons in the CA1 (Andersen, Bliss, & 
Skrede, 1971; Small et al., 2011). The heterogeneity of the pyramidal neurons in the 
Cornu Ammonis (CA) regions remains under investigation, but current research suggests 
that their functional differences may rely on the length of their distal dendrites which 
would modify propensities to fire signals (Cembrowski & Spruston, 2019; Ding et al., 
2020). 
1.2.2 Amino Acid Neurotransmission 
The trisynaptic perforant pathway implements GABAergic neurotransmission via 
laced interneurons and primarily glutamatergic neurotransmission in the granule and 
pyramidal cells, though it has been reported that there is a GABA presence in the granule 
cells and mossy fiber axons (Acsády, Kamondi, Sík, Freund, & Buzsáki, 1998; Münster-
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Wandowski, Gómez-Lira, & Gutiérrez, 2013; Sloviter, 2003). Constitutive activity in the 
trisynaptic pathway involves excitatory input from the entorhinal cortex into the granule 
cells of the DG which release glutamate onto pyramidal cells and interneurons within the 
CA3 and CA2 regions; this results in at least two cellular responses: 1) pyramidal 
neurons in these regions propagate excitatory information into subiculum pyramidal cells 
along the Shaffer collaterals through the pyramidal cells of the CA1; 2) interneurons in 
the CA3, CA2 and CA1 regions regulate and tune pyramidal neuron activity by lateral 
inhibition (Banke & McBain, 2006; O’Mara, 2005; Sloviter, 2003). It is through this 
glutamatergic N-methyl-D-aspartate (NMDA) mechanism that neural plasticity and long-
term potentiation occur in the hippocampus (Collingridge, Kehl, & McLennan, 1983; 
Rebola, Lujan, Cunha, & Mulle, 2008). The interaction of this amino acid 
neurotransmission is fragile and can contribute to mental illness. 
1.2.3 Hippocampal Pathology 
In certain pathogenic states, amino acid neurotransmission is dysregulated. 
Namely, individuals suffering from AD and epilepsy experience heightened hippocampal 
glutamate activity (Barker & White, 2015; Wang & Reddy, 2017), and individuals with 
Schizophrenia have a reduced number of hippocampal GABAergic interneurons resulting 
in unregulated excitation (Konradi et al., 2011). Unbridled glutamate activity can induce 
calcium-mediated mitochondrial dysfunction and excitotoxic neuronal death (Ankarcrona 
et al., 1995; Berliocchi, Bano, & Nicotera, 2005). In addition, one hallmark of excessive 
glutamate activity in the hippocampus is the presence of collateral axonal sprouting and 
reorganization of axons in hyperexcitable pyramidal neurons which is closely associated 
with the effects of temporal lobe epilepsy following a sustained seizure (Sutula, Cascino, 
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Cavazos, Parada, & Ramirez, 1989). The clinical overlap between alcohol-related 
pathologies and epileptic instances should be noted: the prevalence of epilepsy and 
reported history of seizures reaches up to 18%-21% in the FASDs population, which is a 
higher prevalence compared to the general population (Bell et al., 2010; Nicita et al., 
2014). This suggests that there may be a common mechanism of hippocampal 
modification between alcohol-exposure and development of epileptic profiles. 
1.2.4 Convergent Mechanisms 
Rodent research on temporal lobe epilepsy may provide an important link 
between glutamate activity, hippocampal axonal reorganization, and subsequent cognitive 
deficits with relationship to prenatal alcohol exposure. One of the most common 
outcomes for successful induction of temporal lobe epilepsy in rodent models is 
hyperexcitability of glutamatergic neurons in the hippocampus such that firing threshold 
is lower and more sensitive to glutamate (Blümcke et al., 2000; Fritsch, Stott, Joelle 
Donofrio, & Rogawski, 2010). This glutamate-driven hippocampal hyperexcitability can 
induce neuronal cell death and axonal reorganization, an effect which is replicated by 
alcohol exposure and subsequent withdrawal (Ankarcrona et al., 1995; Lindsley, 2006; 
Sutula et al., 1989; Whittington, Lambert, & Little, 1995). In fact, upon withdrawal from 
heavy, chronic alcohol exposure, both humans and rodents routinely present with seizures 
that are perpetuated by robust, imbalanced glutamate activity (Rogawski, 2005). 
1.2.5 Alcohol Action 
Upon initial exposure, alcohol induces an inhibitory effect on cells by GABA 
agonism and glutamatergic antagonism; however, upon withdrawal, alcohol induces a 
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compensatory glutamatergic action, surmounting the inhibitory effects of GABA 
(Whittington et al., 1995). Importantly, the effects of maternal drinking patterns of 
exposure and withdrawal are recapitulated in the developing CNS of the fetus (Thomas & 
Riley, 1998). The differential effects of initial alcohol exposure and subsequent 
withdrawal on axonal and microtubule organization in the developing rodent brain 
remains under investigation. It has been shown that initial alcohol exposure suppresses 
axonal growth and guidance cues, but subsequently exaggerates aberrant axonal 
sprouting and reorganization in the hippocampus that lasts into adulthood; the nature of 
this response may depend on the alcohol dose and the period of CNS development in 
which the alcohol exposure occurs (Hodges & Black, 1981; Lindsley, Kerlin, & Rising, 
2003; Sakata-Haga et al., 2003). The hippocampal region most susceptible to alcohol-
induced microtubule disorganization appears to be the in axonal bend of the intersection 
between the CA3 and CA1; this region is imperative for evolution and maintenance of 
associative memory and may be linked to cognitive deficits seen in rodent models of 
FASDs (Gruart, Muñoz, & Delgado-García, 2006; Sakata-Haga et al., 2003). 
1.2.6 Microtubule Involvement 
  One culprit that may be involved in the poor developmental outcomes associated 
with alcohol-induced axonal disorganization could be the regulating effects of 
microtubule-associated proteins (MAPs) which are sensitive to alcohol exposure and 
have implications in diseased states (Ahluwalia, Ahmad, Adeyiga, Wesley, & Rajguru, 
2000; Evrard et al., 2006; Smith, Butler, & Prendergast, 2013). The sprouting of 
immature axons incorporates MAPs that directly aid in axonal structural support and 
indirectly assist neural migration; one structural protein that is sensitive to alcohol and 
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necessary for appropriate maturation and maintenance of axonal structural support is the 
tau protein (Gendron, McCartney, Causevic, Ko, & Yen, 2008).  Though the tau protein 
is generally investigated with relationship to neurodegenerative diseases such as AD, 
Parkinson’s, and dementia, its role in the structural support and susceptibility to alcohol-
modulation in the developing nervous system must be considered as a potential element 
in the neurodevelopmental profile of FASDs. 
1.3 Tau Protein Function: Modifications and Pathologies 
Tau proteins are highly involved in the structural integrity of axonal processes in 
the central nervous system; the role of tau is integral in several necessary cellular 
activities including tubulin polymerization, synaptogenesis, neural migration, axonal 
transport, and sustained support of cytoskeletal function (Cleveland, Hwo, & Kirschner, 
1977; Dayanandan et al., 1999; Mandelkow, Stamer, Vogel, Thies, & Mandelkow, 2003; 
Wang & Liu, 2008). The regulation and function of the tau protein is dynamic and can be 
altered at the level of genetic expression, alternative splicing, and posttranslational 
modifications in response to cellular insult.  
The tau protein is encoded on human chromosome 17q21 and produces six 
different isoforms from 16 different exons (Neve, Harris, Kosik, Kurnit, & Donlon, 
1986). Tau is in the family of microtubule associated proteins (MAPs) responsible for 
tubulin assembly and structural support in mature cells. Alterations to the tau gene 
differentially result in diminished tau activity, including poor microtubule binding, an 
effect which can result in neurodevelopmental delay and/or degeneration (Bunker, 
Kamath, Wilson, Jordan, & Feinstein, 2006; Hong et al., 1998; Shaw-Smith et al., 2006). 
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While not all alterations to the tau gene are associated with any specific pathology, the 
alternative splicing of tau exon 10 produces isoforms that include either 3 (3R) or 4 (4R) 
microtubule-binding site repeats with functional and pathogenic impacts (Panda, Samuel, 
Massie, Feinstein, & Wilson, 2003). Functionally, 4R tau isoforms have triple 
microtubule binding capacity than do 3R tau isoforms (D'Souza & Schellenberg, 2005). 
In the non-pathogenic human adult brain, the ratio of 3R to 4R tau isoforms is 1:1 and 
alterations to this ratio are observed in neurodegenerative diseases such as Parkinson’s 
and Down’s syndrome (Heutink, 2000; Yoshida, 2006). Importantly, fetal tau isoforms in 
both rodents and humans express only 3 microtubule binding repeats suggesting a 
temporal regulation of tau function (Bunker, Wilson, Jordan, & Feinstein, 2004). There is 
evidence that tau expression and function is genetically regulated, but posttranslational 
modifications substantially interfere with constitutive tau activity and can promote 
pathogenic susceptibility. The tau protein is posttranslationally modified primarily by 
ubiquitination, glycosylation, and phosphorylation. 
1.3.1 Ubiquitination 
Ubiquitination of the tau protein results in proteolytic degradation and clearance 
of the protein. Ubiquitination is site specific on the tau protein with functionally distinct 
proteolytic activity; in the pathogenic state, tau proteins are ubiquitinated by at least three 
linkages: Lysine 6, Lysine 11, and Lysine 48 (Wang & Liu, 2008). These linkages have 
different outcomes for the tau proteins wherein Lysine 48 is necessary for proteolytic 
recruitment, but Lysine 6 appears to be protective against proteasome recruitment (Cripps 
et al., 2006). Importantly, ubiquitination is critical for degradation of misfolded proteins 
that aggregate and jeopardize cell viability if left unmodified. For instance, proteolytic 
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stress triggers heat shock protein-70 (Hsp70) which interacts with C-terminus of Hsc70-
interacting protein (CHIP) ubiquitin ligase, or collectively the E3 ligase; this interaction 
is effective for clearance of misfolded tau proteins seen in tauopathic brains (Connell et 
al., 2001). Moreover, the Hsp70-CHIP interaction is being considered as a diagnostic and 
therapeutic tool for tauopathies because of its elevated activity in tauopathies such as AD 
(Kumar, Jha, Jha, Ramani, & Ambasta, 2015). In fact, Hsp70-CHIP activity appears to 
coincide with hyperphosphorylation of the tau protein, a cardinal correlate of tauopathies 
(Shimura, Schwartz, Gygi, & Kosik, 2004). 
1.3.2 Glycosylation 
Glycosylation is a modification involving the attachment of a carbohydrate group 
to an amine side chain (N-linked) or a hydroxyl group (O-linked) of a protein which 
alters its structure and function. Glycosylation and deglycosylation are site-specific on 
the tau protein and have functional differences dependent on glycosylation site (Gong, 
Liu, Grundke-Iqbal, & Iqbal, 2005). Specifically, O-linked monosaccharide β-N-
acetylglucosamine glycosylation, or O-GlcNAcylation, occurs when the monosaccharide 
molecule is attached to the hydroxyl group of the serine or threonine residues of the tau 
protein.  This glycosylation can result in subsequent downstream tau phosphorylation that 
may induce aberrant tau protein aggregation and/or neuronal membrane permeability, 
subcellular hallmarks of neurodegenerative diseases such as dementia and AD (Arnold et 
al., 1996; Lui et al., 2002; Takahashi et al., 1999; Torres & Hart, 1984; Wang, Grundke-
Iqbal, & Iqbal, 1996; Yuzwa & Vocadlo, 2014). Thus, glycosylation may be involved in 
the initiation and maintenance of the cytosolic and structural abnormalities resulting from 
tau hyperphosphorylation. 
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1.3.3 Hyperphosphorylation 
Hyperphosphorylation is the result of overactive kinase activity wherein 
phosphate molecules are attached at various residue sites of proteins which can impede 
on protein function. Hyperphosphorylation of the tau protein is one hallmark of 
neurodegenerative pathologies, though the phosphorylation state of the tau protein is 
regulated throughout CNS development in a non-pathogenetic manner (Iqbal, Liu, Gong, 
& Grundke-Iqbal, 2010). The most clinically investigated tauopathy is AD, which 
involves hippocampal and entorhinal cortical white-matter degeneration, unregulated tau 
phosphorylation, development of amyloid-β plaques, and neuronal death, all of which 
contribute to progressive loss of memory and cognitive function (for a review, see Orr, 
Sullivan, & Frost, 2017). The mechanisms of phosphorylation rely on kinase activity at 
one or several phosphorylation sites on the protein structure. For example, glycogen 
synthase kinase-3β (GSK-3β) phosphorylation of the tau protein upstream from 
(Threonine 231) or directly on the microtubule-binding domain (Serine 262) disrupts the 
optimal binding capacity and structural function of the tau protein in diseased states 
(Gong et al., 2005). Tau interacts with several kinases, but GSK-3β is an attractive 
candidate due to its developmental regulation and sensitivity to alcohol.  
GSK-3β activity is implicated in the developing fetus where its role is dynamic 
and highly involved in the regulation of cellular glucose metabolism and subsequent 
neuronal maturation (Jope & Johnson, 2004). As a kinase, GSK-3β is a protein structure 
with its own amino acid residues that can be ubiquitinated, glycosylated, and 
phosphorylated which dictate its activity.  When GSK-3β is dephosphorylated at its 
Serine 9 site, it becomes active and such action is elevated following alcohol exposure 
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(Chen et al., 2009). It has been reported that unregulated activity of GSK-3β may be 
related to alcohol-driven compensatory Ca2+ activity (Hartigan & Johnson, 1999). GSK-
3β overactivity can result in deleterious fetal effects regarding neurite outgrowth, axon 
extension, and microtubule function in the developing CNS which are directly related to 
the phosphorylation state of the tau protein; GSK-3β overactivity increases tau 
phosphorylation at several amino acid residues and impairs the protein function (Dill, 
Wang, Zhou, & Li, 2008; Xu et al., 2004). 
1.4 Purpose 
Taken together, the observations outlined in the sections above would suggest: (1) 
fetal alcohol exposure aberrantly affects microtubule organization in the hippocampus; 
(2) this effect is likely modified by alcohol-induced Ca2+ activity which affects fetal
axonal arrangement and increases GSK-3β activity; (3) resulting in sustained tau 
phosphorylation within fetal hippocampal axons. We hypothesize that phosphorylated tau 
protein immunofluorescence will decrement in control slices; however, we predict that 
this immunofluorescence will not decrement in slices that are exposed to alcohol. The 
role of alcohol exposure on tau protein phosphorylation in the developing hippocampus is 
explored below. 
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CHAPTER 2. METHODS 
2.1 Organotypic Hippocampal Slice Culture 
Ten-day-old male and female Sprague Dawley pups (Harlan Laboratories; 
Indianapolis, IN) were humanely euthanized and full brains were aseptically removed and 
placed into chilled dissecting media solution containing: Minimum Essential Media 
(MEM; Invitrogen, Carlsbad, CA), 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES; Sigma, St. Louis, MO), streptomycin/penicillin (Invitrogen), and Amphotericin 
B solution (Sigma). Brains were then midsagittally transected, and hippocampi were 
removed. Any excess tissue that was attached to the hippocampi following harvest was 
removed using a No. 15 scalpel. These hippocampi were then flatly positioned upon a 
plastic platform and sectioned into 200µm slices using the McIllwain Tissue Chopper 
(Mickle Laboratory Engineering Co. Ltd., Gomshall, UK). Slices which retained the 
CA1, CA3, Genu, and Dentate Gyrus (DG) were then selected to be plated upon Millicell 
biopore membranes (0.4μm, 30mm diameter; MilliporeSigma, Burlington, 
Massachusetts); each membrane supported 3 to 4 hippocampal slices to prevent tissue 
overlap. Membranes were then inserted into 6-well plates (5mL, 9.5cm2 area; VWR, 
Radnor, PA) containing approximately 1.5mL of culturing media for humidity-controlled 
incubation at 37 °C, 5% CO2, and 95% air. Any excess culturing media that pooled atop 
the membrane or around any of the hippocampal slices was removed using a micropipette 
to improve slice adherence and ensure oxygen exposure. Slices were permitted 6 days of 
uninterrupted incubation to heal from removal and securely anchor into the membrane 
prior to any manipulations. 
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2.2 Experiment 1: Temporal Assessment of Tau Protein Phosphorylation in the 
Hippocampus 
At 6 days in vitro (DIV), slices were either transferred into fresh culture media for 
later assessment or underwent the IHC procedure for assessment of tau phosphorylation 
at 6DIV. The IHC procedure recurred incrementally at 12DIV, 18DIV, and 24DIV to 
track the trajectory of tau phosphorylation states across the experimental timeline (Figure 
2.2.1). Regions of interest in Experiment 1 included the CA1, CA3, and DG of the 
hippocampus (Figure 2.2.2). 
 
Figure 2.2.1 Experimental Timeline. Schematic of timepoints measuring tau phosphorylation 
across 6DIV, 12DIV, 18DIV, and 24DIV. 
Figure 2.2.2 Regions of Interest for Experiment 1. Schematic of areas of interest in the 
temporal decrement of tau protein phosphorylation. 
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2.3 Experiment 2 Effect of Initial Alcohol Exposure on Temporal Decrement of Tau 
Protein Phosphorylation in the Hippocampus 
Experiment 2 assessed tau phosphorylation in the CA1, CA3, DG, and genu of the 
hippocampus at four timepoints: 6DIV, 12DIV, 18DIV, 24DIV. At each timepoint 
following 6DIV, there was an EtOH-exposed condition and a control condition. Control 
slices received plain culture media at all timepoints. Experimental slices received five 
days of 50mM EtOH exposure in culture media from 6DIV to 11DIV, and then received 
plain culture media for the remainder of the experimental timeline; this was meant to 
mimic a human third-trimester equivalent maternal alcohol binge of approximately 
0.23BAC.  
Plates housing control slices were placed into a Tupperware container with 50mL 
of distilled water and placed into a Ziploc bag, filled with 5% CO2 and 95% air, and then 
sealed and placed into the incubator. Ethanol-exposed slices which received 50mM 
ethanol media between 6-11DIV were similarly placed in a Tupperware with 50mM 
ethanol water, placed into a Ziploc bag filled with 5% CO2 and 95% air, and then sealed 
and placed into the incubator. Atmospheric treatment was meant to prevent alcohol 
evaporation during the five-day exposure. Regions of interest in Experiment 2 included 
the CA1, CA3, DG, and genu of the hippocampus (Figure 2.3.1). Because the 
modifications of interest for this experiment involve the effect of ethanol on tau protein 
phosphorylation associated with immature microtubules within mossy fibers and Shaffer 
collaterals between the CA3 and CA1, we included the additional measure of the 
hippocampal genu to comprehensively address changes in tau protein phosphorylation in 
and between these regions following alcohol exposure. Because this area is an ambiguous 
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and contested region, traditional cytographic regional distinctions did not suffice for 
exhaustive exploration of tau phosphorylation.  
2.4 Immunohistochemistry Procedure 
For analysis of tau phosphorylation using immunohistochemistry (IHC), all slices 
were first fixed in 10% formalin. Then the slices were washed twice in 1x PBS solution 
and placed into an IHC buffer solution containing: 1x PBS, Triton detergent, and Bovine 
Serum Albumin for 30 minutes. After, slices were again washed twice in 1x PBS 
solution. The primary antibody used in these experiments was Phospho-Tau (Thr231) 
Monoclonal Antibody (AT180) (Thermo Fisher, Waltham, MA). The antibody was 
diluted 1:40 in IHC buffer solution and administered onto slices for 24 hours at 4°C; the 
slices were then washed twice in 1x PBS. The secondary antibody used in these 
experiments was Goat anti-Mouse IgG (H+L) Secondary Antibody, TRITC (Thermo 
Fisher). The secondary antibody was diluted 1:200 in IHC buffer solution and 
administered onto slices for 24 hours at 4°C; the slices were then washed twice in 1x PBS 
prior to microscopic fluorescent imaging at 570 nm. Fluorescent intensity of all imaged 
Figure 2.3.1 Regions of Interest for Experiment 2. Schematic of areas of interest in the 
temporal decrement of tau protein phosphorylation following an initial 5-day alcohol 
exposure. 
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slices was measured using optical densitometry where greater fluorescent intensity 
indicated greater concentration of threonine 231 phosphorylation on tau proteins.  
2.5 Statistical Analysis  
Statistical analyses were conducted to determine the effect of age and alcohol 
exposure on the fluorescence of phosphorylated tau proteins in the hippocampus. 
Multilevel model regression analyses were conducted in SAS using the DG as the 
reference region for both Experiments 1 and 2 unless otherwise noted. The variables that 
were included in the analyses were the effect of sex (male or female), EtOH exposure, 
age, and an interaction between EtOH and age. Model assumptions were not violated. 
Significance level was set at p ≤ 0.05, but marginal significance was reported if p ≤ 0.1. 
Figures from Experiment 2 have been linearly transformed such that values are depicted 
as %6DIV.  
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CHAPTER 3. RESULTS 
3.1 Experiment 1. 
Results of multilevel models are presented in Table 3.1.1. The initial unconditional 
means model (Model A) indicated an ICC of 0.38. Next, hippocampal region (CA1, 
CA3) was added to the model, which significantly improved model fit, Δ deviance = 
83.9, p < 0.001 (Model B). Adding male to the model did not significantly improve 
model fit, Δ deviance = 1.4, n.s., and was therefore removed (Model C). However, adding 
age to the model did significantly improve model fit, Δ deviance = 42.1, p < 0.001 
(Model D). Evaluation of model coefficients indicated that age was a significant predictor 
of the Level 1 intercept but not the effects of CA1 or CA3. Therefore, an additional 
model was fit removing these interaction terms from the model (Model E). This model fit 
the data equally well as Model D, Δ deviance = 3.0, n.s., and is therefore the preferred 
model due to parsimony. 
In Model E, intensity is estimated to be 24.83, p < 0.001, for the DG region at 6DIV. 
Intensity is 4.43, p < 0.001, lower for each subsequent age group (12DIV, 18DIV, and 
24DIV). These age group differences are the same for each region (Figure 3.1.1). However, 
overall intensity is 7.81, p < 0.001, higher in the CA1 region compared to the DG region. 
Intensity was equivalent for CA3 and DG regions. 
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Effect Model A Model B Model C Model D Model E 
Intercept 
    
 
    Intercept 20.89*** 18.23*** 18.73*** 24.28*** 24.83*** 
    Male   -1.20   
    Age    -4.07*** -4.43*** 
    Residual Var 18.88** 25.51*** 24.96*** 7.30** 7.17** 
CA1      
    Intercept  7.81*** 8.22*** 9.49*** 7.81*** 
    Male   -1.00   
    Age    -1.13  
CA3      
    Intercept  0.18 0.19 0.13 0.18 
    Male   -0.03   
    Age    0.03  
Level 1 Res Var 31.04*** 11.16*** 11.09*** 10.76*** 11.16*** 
Deviance 814.2 730.3 728.9 686.8 689.8 
Delta Deviance  83.9*** 1.4 42.1*** 3 
Table 3.1.1 Results from the multilevel model analysis for Experiment 1. 
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Figure 3.1.1 Average effect of days in vitro on p-Tau Thr231 immunofluorescence 
across 6, 12, 18, and 24DIV. 
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3.2 Experiment 2 
Results of multilevel models are presented in Table 3.2.1. The initial unconditional 
means model (Model A) indicated an ICC of 0.55. Next, hippocampal region (CA1, CA3, 
and Genu) was added to the model, which significantly improved model fit, Δ deviance = 
219.00, p < 0.001 (Model B). Adding male to the model did not significantly improve 
model fit, Δ deviance = 6.1, n.s., and was therefore removed (Model C). However, adding 
age to the model did significantly improve model fit, Δ deviance = 22.6, p < 0.001 
(Model D), as did adding EtOH, Δ deviance = 20.2, p < 0.001 (Model E), and the 
interaction between Age and EtOH, Δ deviance = 15.9, p < 0.01 (Model F). Therefore, 
Model F was the preferred model. 
Model F (Table 3.2.1) indicated the mean intensity for control samples at 6DIV in 
the DG region was 21.11, p < 0.001. Intensity is 1.76, p < 0.001, lower for each 
subsequent age group (12DIV, 18DIV, and 24DIV) for control samples in the DG region. 
Intensity is 5.44, p < 0.001, higher in the CA1 region compared to the DG region in 
control samples at 6DIV. There is a significant difference in intensity between EtOH 
samples in the Genu region compared to the DG region at 6DIV but not between control 
samples, 2.44, p < 0.05.  
Model F also indicated a significant EtOH by Age interaction due to the 
significant improvement in model fit. However, none of these interaction terms were 
significant when using DG as the reference region. Further probing of the interaction 
identified significant terms only when CA1 was the reference region. Specifically, the 
EtOH by Age interaction significantly predicted the difference between CA1 and CA3 on 
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intensity, -2.21, p < 0.001 and marginally predicted the difference between CA1 and genu 
on intensity, -1.20, p = 0.06 and the difference between CA1 and DG on intensity, -1.23, 
p = 0.06.  
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Effect Model A Model B Model C Model D Model E Model F  
Intercept 
    
  
    Intercept 20.23*** 18.35*** 18.71*** 20.38*** 20.24*** 21.11*** 
    Male   -0.67    
    Age    -1.24*** -1.24*** -1.76*** 
   EtOH     0.26 -1.71 
   EtOHxAge       1.20 
   Residual Var 24.20*** 25.50*** 25.50*** 23.40*** 23.25*** 22.84*** 
CA1       
    Intercept  5.11*** 4.91*** 4.79*** 4.55*** 5.44*** 
    Male   0.38    
    Age    0.20 0.20 -0.33 
   EtOH     0.45 -1.56 
   EtOHxAge      1.23 
CA3       
    Intercept  0.59 0.34 1.29* 1.32 0.61 
    Male   0.46    
    Age    -0.43 -0.43 -0.00 
    EtOH     -0.05 1.55 
    EtOHxAge      -0.98 
Genu       
   Intercept  1.81*** 1.45** 2.24*** 0.94 0.96 
   Male   0.66    
   Age    -0.26 -0.24 -0.25 
   EtOH     2.49*** 2.44* 
   EtOHxAge      0.03 
Level 1 Res Var 20.03*** 14.81*** 14.81*** 14.73*** 14.37*** 14.14*** 
Deviance 6075.1 5856.1 5850.0 5833.5 5813.3 5797.4 
Delta Deviance  219*** 6.1 22.6*** 20.2*** 15.9** 
Table 3.2.1 Results from the multilevel model analysis for Experiment 2. 
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3.2.1 Differences in intensity across age groups based on region and EtOH exposure 
Additional probing of the EtOH by Age interaction terms revealed that there was 
a significant effect of age for control samples in each of the four regions: -1.76, p < 0.001 
for DG (Figure 3.2.1.1); -1.76, p < 0.001 for CA3 (Figure 3.2.1.2); -2.09, p < 0.001 for 
CA1 (Figure 3.2.1.3); -2.01, p < 0.001 for genu (Figure 3.2.1.4). However, there was only 
a significant effect of age for EtOH samples in the CA3 region, -1.53, p < 0.01 (Figure 
3.2.1.2). There was no significant effect of age for the other three regions: -.56 for DG 
(Figure 3.2.1.1); .34 for CA1 (Figure 3.2.1.3); -.78 for genu (Figure 3.2.1.4). In the CA1 
region, the effect of age was significantly stronger for control samples than EtOH 
samples, 2.43, p < 0.001. In the genu region, the effect of age was marginally stronger for 
control samples than EtOH samples, 1.24, p = 0.09. The figures for the regional means 
for these data have been linearly transformed by the 6DIV average for their respective 
condition, such that condition is represented as %6DIV.  
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Figure 3.2.1.1 Effect alcohol and days in vitro on p-Tau Thr231 immunofluorescence 
across 12, 18, and 24DIV in the dentate gyrus, shown as %6DIV. Tau phosphorylation 
significantly declined between 6DIV and 24DIV for control samples, B = -1.76, p < 
0.001. Tau phosphorylation did not significantly change between 6DIV and 24DIV for 
samples exposed to alcohol, B = -0.56, n.s.  
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Figure 3.2.1.2 Effect alcohol and days in vitro on p-Tau Thr231 immunofluorescence 
across 12, 18, and 24DIV in the CA3, shown as %6DIV. Tau phosphorylation 
significantly declined between 6DIV and 24DIV for both control samples, B = -1.76, 
p < 0.001 and samples exposed to alcohol, B = -1.53, p < 0.01. 
30 
Figure 3.2.1.3 Effect alcohol and days in vitro on p-Tau Thr231 immunofluorescence 
across 12, 18, and 24DIV in the CA1, shown as %6DIV. Tau phosphorylation 
significantly declined between 6DIV and 24DIV for control samples, B = -2.09, p < 
0.001. Tau phosphorylation did not significantly change between 6DIV and 24DIV for 
samples exposed to alcohol, B = 0.34, n.s.  
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Figure 3.2.1.4 Effect of alcohol and days in vitro on p-Tau Thr231 
immunofluorescence across 12, 18, and 24DIV in the hippocampal genu, shown as 
%6DIV. Tau phosphorylation significantly declined between 6DIV and 24DIV for 
control samples, B = -2.01, p < 0.001. Tau phosphorylation did not significantly 
change between 6DIV and 24DIV for samples exposed to alcohol, B = -0.78, n.s.  
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CHAPTER 4. DISCUSSION 
4.1 Implications 
Because the role of phosphorylated tau protein in the developing nervous system 
has received little to no experimental or clinical attention, we intended to explore its 
relationship with alcohol to draw implications related to FASDs. Above we have shown 
that, under control conditions across 24 days in vitro (DIV), the fluorescence of 
phosphorylated tau protein decrements in all regions of the rat hippocampus studied. 
However, this effect is widely absent in tissue that encountered alcohol. 
4.1.1 Experiment 1 
In Experiment 1, we established the decremental nature of phosphorylated tau 
fluorescence in the CA1, CA3, and DG over brief in vitro neonatal hippocampal 
development. Because tau phosphorylation is elevated and associated with axonal 
disorganization before and at birth, we anticipated that phosphorylated tau protein 
fluorescence would be the brightest in the hippocampus when imaged closer to birth 
(Brion, Smith, Couck, Gallo, & Anderto, 1993); the reduction of tau phosphorylation 
from 6DIV to 24DIV, therefore, was unsurprising considering the control condition 
permitted an unmodified environment for culturing healthy tissue.  
The reduction in phosphorylated tau protein fluorescence could be a result of at 
least two temporally regulated and functionally related processes that converge within the 
insulin pathway: 1) diminished kinase activity of the GSK-3β protein, and/or 2) increased 
phosphatase activity of protein phosphatase 2A (PP2A). As previously discussed, GSK-
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3β phosphorylates the tau protein at several amino acid residues, and GSK-3β is directly 
implicated in the hyperphosphorylated state of the tau protein in damaged or diseased 
hippocampi (Gong et al., 2005). Because GSK-3β is dynamically regulated during the 
development and maturation of cells, GSK-3β activity may be associated with the 
phosphorylation state of the tau protein across the duration of tissue culturing, such that, 
as the tissue matured in vitro, GSK-3β hyperactivity became relatively stable under 
control conditions which concurrently reduced tau protein phosphorylation (Jope & 
Johnson, 2004).  
Just as kinase activity is involved with phosphorylation of proteins, phosphatase 
activity is involved with dephosphorylation of proteins. The most abundantly known 
phosphatase in the CNS is the PP2A phosphatase which is responsible for 
dephosphorylating 70%-90% of phosphorylated proteins, including the tau protein (Liu, 
Grundke-Iqbal, Iqbal, & Gong, 2005; Eichhorn, Creyghton, & Bernards, 2009). In fact, 
the phosphorylation state of serine/threonine residues on the tau protein is chiefly 
regulated by GSK-3β phosphorylation and PP2A dephosphorylation, where PP2A 
dephosphorylation is necessary for cellular morphogenesis and maturation (Avila, 2008; 
Olsen et al., 2006). It is likely the inverse relationship between GSK-3β and PP2A that 
resulted in the decrement of tau phosphorylation under control conditions in our tissue, 
though metrics directly assessing the roles of PP2A and GSK-3β were not included in 
these experiments.  
4.1.2 Experiment 2 
In Experiment 2, we established the decremental nature of phosphorylated tau 
protein in the CA1, CA3, DG, and Genu over brief in vitro neonatal hippocampal culture 
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in the control condition; however, when tissue encountered alcohol, subsequent culturing 
indicated that fluorescence of tau phosphorylation does not significantly change from 
6DIV to 24DIV in the CA1, DG, or Genu. Our hypothesis regarding the temporally 
sustained nature of tau phosphorylation in the alcohol-treated slices was supported by 
these findings, except in the CA3 region. This is not unsurprising considering the 
heterogeneity of glutamatergic NMDA receptor densities on pyramidal cell bodies within 
the hippocampal subregions; autoradiographic experiments measuring [125I]MK-801 
binding show that the CA1 region has the highest density of NMDARs compared to the 
CA3 and DG regions (Butler et al., 2010). Because the hypothesized effect of alcohol 
exposure and subsequent withdrawal is ultimately Ca2+-driven with relationship to GSK-
3β, higher densities of NMDARs would indicate a greater susceptibility to Ca2+-related 
kinase activity (Dill, Wang, Zhou, & Li, 2008; Hartigan & Johnson, 1999; Xu et al., 
2004); this NMDAR/Ca2+ rationale, however, does not explain why tau phosphorylation 
in the DG was sensitive to alcohol, but not the CA3, considering no significant 
differences in NMDAR densities between the regions exist. Further investigation should 
consider differential expression of GSK-3β by region. The heterogeneity of tau 
phosphorylation between the CA3 and other hippocampal regions could illuminate 
differences between mossy fiber and Shaffer collateral axonal development and how 
constitutive tau phosphorylation and function is modified by alcohol exposure. 
One possible explanation for the sustained p-tau florescence following alcohol 
withdrawal is that the inverse relationship between PP2A and GSK-3β may have been 
disrupted by alcohol exposure such that competition for phosphate homeostasis was 
amplified and preferential for GSK-3β in the presence of cellular insult. The association 
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between alcohol exposure, elevated Ca2+, and GSK-3β hyperactivity supports this 
hypothesis (Chen et al., 2009; Hartigan & Johnson, 1999). As previously mentioned, 
GSK-3β activity is primarily dictated by a cascade of events originating at the insulin 
receptor, a receptor which becomes less sensitive to insulin following alcohol exposure, 
promoting GSK-3β (Seiler, Henderson, & Rubin, 2000).  This element of GSK-3β tau 
hyperphosphorylation resulting from insulin insensitivity is well-established; however, 
the role of PP2A and insulin signaling in relationship to tau hyperphosphorylation 
remains under investigation (for a review, see Mandavia & Sowers, 2012). 
4.2 Limitations 
Notably, the fluorescence of tau phosphorylation is sustained following alcohol 
exposure – whether that is the sustained phosphorylation of initially-expressed tau 
proteins or detection of newly-expressed phosphorylated tau proteins remains unclear. 
There is evidence that alcohol increases total tau protein concentrations (Hoffman et al., 
2019); therefore, it is possible that alcohol simply increased the expression of tau proteins 
phosphorylated at threonine 231 (Thr231) rather than sustaining the initial tau 
phosphorylation state. It may be erroneous to assume that tau phosphorylation is 
saturated and immunofluorescent intensity is highest at birth, despite what we have 
shown here. The functional difference between newly expressed Thr231 phosphorylated 
tau proteins and sustained Thr231 phosphorylation on initially expressed tau proteins 
would be difficult to discriminate in our model. Total tau immunofluorescence may be an 
avenue to consider.
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 The organotypic hippocampal slice culture (OHSC) model is integral for 
investigating histological changes in developmental pathologies of neural tissues that are 
otherwise inaccessible in humans. OHSC minimizes animal resources with an unmatched 
degree of experimental control which is necessary for delineation of biochemical 
pathways and subsequent potential therapeutic targets. However, the benefits of the 
OHSC model are also its limitations: the tissue is divorced from the rest of the CNS and 
peripheral nervous system (PNS) which are elements, in conjunction with learning and 
behavior, that would undoubtedly influence CNS development with regard to alcohol 
exposure. 
We are interpreting the decrement of phosphorylated tau protein fluorescence as a 
crude indication of axonal organization and maturation, though no complementary 
confirmation was utilized in these experiments. Using myelin basic protein staining may 
be an avenue by which such a confirmation could be made, where an inverse interaction 
would better indicate axonal maturation and could provide insight into the relationship 
between tau phosphorylation and neonatal myelination.  
Finally, while our findings demonstrate that tau protein phosphorylation remains 
elevated in all regions of the hippocampus except the CA3 following alcohol exposure, 
these findings do not indicate that sustained tau phosphorylation confers any behavioral 
or cognitive abnormalities observed in rodent models of or human patients with FASDs. 
Taken together, behavioral and cognitive translational work must be conducted to 
legitimize FASDs as a tauopathy in order to proceed with any meaningful therapeutic 
pursuits.  
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